Opportunities for Enhancing the FDA Guidance on Pharmacovigilance
Psaty and Vandenbroucke
JAMA 2008;300:952-954.
FULL TEXT
Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
Alsheikh-Ali et al.
J Am Coll Cardiol 2008;0:j.jacc.2008.06.037v1-14098.
ABSTRACT
| FULL TEXT
The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
Hilgers and Mann
Nephrol Dial Transplant 2008;0:gfn455v1-gfn455.
FULL TEXT
Do People With Diabetes Need Statins?
White
The Diabetes Educator 2008;34:664-673.
ABSTRACT
| FULL TEXT
Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
Norris et al.
ANN INTERN MED 2008;148:855-868.
ABSTRACT
| FULL TEXT
Effect of Pretreatment With Statins on Ischemic Stroke Outcomes
Reeves et al.
Stroke 2008;39:1779-1785.
ABSTRACT
| FULL TEXT
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
Howard et al.
JAMA 2008;299:1678-1689.
ABSTRACT
| FULL TEXT
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Mizuno et al.
Circulation 2008;117:494-502.
ABSTRACT
| FULL TEXT
Generalizability of the Results of Randomized Trials
Weiss et al.
Arch Intern Med 2008;168:133-135.
FULL TEXT
Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
Afilalo et al.
J Am Coll Cardiol 2008;51:37-45.
ABSTRACT
| FULL TEXT
Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort
Flick et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2218-2225.
ABSTRACT
| FULL TEXT
Renin: friend or foe?
Brown
Heart 2007;93:1026-1033.
ABSTRACT
| FULL TEXT
Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
Bonovas et al.
JCO 2007;25:3462-3468.
ABSTRACT
| FULL TEXT
Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus
Riche and McClendon
Am J Health Syst Pharm 2007;64:1603-1610.
ABSTRACT
| FULL TEXT
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights From Large Randomized Statin Trials
Alsheikh-Ali et al.
J Am Coll Cardiol 2007;50:409-418.
ABSTRACT
| FULL TEXT
Cerebral Vascular Dysfunction During Hypercholesterolemia
Kitayama et al.
Stroke 2007;38:2136-2141.
ABSTRACT
| FULL TEXT
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT
The Role of Statins in Primary Prevention of Cardiovascular Disease
Eichler et al.
Arch Intern Med 2007;167:1100-1100.
FULL TEXT
Lipid-Lowering Therapy and Outcomes in Heart Failure
Ray et al.
J CARDIOVASC PHARMACOL THER 2007;12:27-35.
ABSTRACT
Does pravastatin promote cancer in elderly patients? A meta-analysis
Bonovas and Sitaras
CMAJ 2007;176:649-654.
ABSTRACT
| FULL TEXT
Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management
Berry et al.
J Am Coll Cardiol 2007;49:631-642.
ABSTRACT
| FULL TEXT
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
Robinson et al.
Stroke 2007;38:441-450.
ABSTRACT
| FULL TEXT
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT
The Effect of Modifiable Risk Factors on Pancreatic Cancer Mortality in Populations of the Asia-Pacific Region
Ansary-Moghaddam et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2435-2440.
ABSTRACT
| FULL TEXT
Statin Therapy after Stroke or Transient Ischemic Attack
Cohen et al.
NEJM 2006;355:2368-2371.
FULL TEXT
Primary Prevention of Cardiovascular Diseases With Statin Therapy: A Meta-analysis of Randomized Controlled Trials
Thavendiranathan et al.
Arch Intern Med 2006;166:2307-2313.
ABSTRACT
| FULL TEXT
Multitherapy for diabetes.
Vos
CMAJ 2006;175:1246-1247.
FULL TEXT
Statins, Fibrates, and Melanoma Risk: a Systematic Review and Meta-analysis.
Freeman et al.
JNCI J Natl Cancer Inst 2006;98:1538-1546.
ABSTRACT
| FULL TEXT
Analysis of Efficacy and Safety in Patients Aged 65-75 Years at Randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
Neil et al.
Diabetes Care 2006;29:2378-2384.
ABSTRACT
| FULL TEXT
Statins and Cancer Risk: A Literature-Based Meta-Analysis and Meta-Regression Analysis of 35 Randomized Controlled Trials
Bonovas et al.
JCO 2006;24:4808-4817.
ABSTRACT
| FULL TEXT
The Argument Against the Appropriateness of Over-the-Counter Statins
Barter and Rye
Circulation 2006;114:1315-1320.
FULL TEXT
Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Molitch
CJASN 2006;1:1090-1099.
ABSTRACT
| FULL TEXT
Statins for primary prevention in type 2 diabetes
DTB 2006;44:57-60.
ABSTRACT
| FULL TEXT
Statins in the treatment of chronic heart failure: Biological and clinical considerations
van der Harst et al.
Cardiovasc Res 2006;71:443-454.
ABSTRACT
| FULL TEXT
A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
Knopp et al.
Diabetes Care 2006;29:1478-1485.
ABSTRACT
| FULL TEXT
Statins and the Risk of Cancer
Freeman et al.
JAMA 2006;295:2720-2721.
FULL TEXT
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT-TIMI 22 Study
Scirica et al.
J Am Coll Cardiol 2006;47:2326-2331.
ABSTRACT
| FULL TEXT
Statin-Induced Myopathy: The Two Faces of Janus
Arora et al.
J CARDIOVASC PHARMACOL THER 2006;11:105-112.
ABSTRACT
Effects of Bezafibrate on HDL2/HDL3 Ratio in Postmenopausal Hypertriglyceridemic Women
Ushiroyama et al.
J CARDIOVASC PHARMACOL THER 2006;11:142-148.
ABSTRACT
Assessment of Patients' and Physicians' Compliance to an ACE Inhibitor Treatment Based on Urinary N-Acetyl Ser-Asp-Lys-Pro Determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study.
Azizi et al.
Diabetes Care 2006;29:1331-1336.
ABSTRACT
| FULL TEXT
Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley et al.
JNCI J Natl Cancer Inst 2006;98:700-707.
ABSTRACT
| FULL TEXT
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute
Smith et al.
J Am Coll Cardiol 2006;47:2130-2139.
FULL TEXT
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute
Smith et al.
Circulation 2006;113:2363-2372.
FULL TEXT
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials
Costa et al.
BMJ 2006;332:1115-1124.
ABSTRACT
| FULL TEXT
Introduction: Pharmacotherapy for Dyslipidemia
Dumo
Journal of Pharmacy Practice 2006;19:61-62.
What's New? Guidelines and Goals
Wigle and Birtcher
Journal of Pharmacy Practice 2006;19:103-112.
ABSTRACT
Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive Subjects
Smith et al.
Hypertension 2006;47:771-777.
ABSTRACT
| FULL TEXT
Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia
Jenkins et al.
Am. J. Clin. Nutr. 2006;83:582-591.
ABSTRACT
| FULL TEXT
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
Ginsberg
J. Clin. Endocrinol. Metab. 2006;91:383-392.
ABSTRACT
| FULL TEXT
Stats on Statins: Anything but Static
McLaughlin
JNCI J Natl Cancer Inst 2006;98:4-5.
FULL TEXT
Cholesterol-Lowering Drugs and Colorectal Cancer Incidence in a Large United States Cohort
Jacobs et al.
JNCI J Natl Cancer Inst 2006;98:69-72.
ABSTRACT
| FULL TEXT
Statins and Cancer Risk: A Meta-analysis
Dale et al.
JAMA 2006;295:74-80.
ABSTRACT
| FULL TEXT
Lipid Management in Type 2 Diabetes
Solano and Goldberg
Clin. Diabetes 2006;24:27-32.
ABSTRACT
| FULL TEXT
Quality Assessment of Dyslipidemia in Managed Care: Current Best Evidence Should Be Used to Benchmark Quality
Nair and Saseen
The Annals of Pharmacotherapy 2006;40:124-127.
ABSTRACT
| FULL TEXT
The Role of Statins in Cancer Therapy.
Hindler et al.
The Oncologist 2006;11:306-315.
ABSTRACT
| FULL TEXT
Use of Statins and Breast Cancer: A Meta-Analysis of Seven Randomized Clinical Trials and Nine Observational Studies
Bonovas et al.
JCO 2005;23:8606-8612.
ABSTRACT
| FULL TEXT
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?: A Meta-Regression Analysis
Robinson et al.
J Am Coll Cardiol 2005;46:1855-1862.
ABSTRACT
| FULL TEXT
Managing Abnormal Blood Lipids: A Collaborative Approach
Fletcher et al.
Circulation 2005;112:3184-3209.
ABSTRACT
| FULL TEXT
Statins and Cancer Development
Duncan et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1897-1898.
ABSTRACT
| FULL TEXT
The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient
Ong
QJM 2005;98:599-614.
ABSTRACT
| FULL TEXT
Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?: Results from 25 years of follow-up in the Renfrew and Paisley Survey
Whiteley et al.
Diabetes Care 2005;28:1588-1593.
ABSTRACT
| FULL TEXT
The realities of dyslipidaemia: what do the studies tell us?
Kastelein
Eur Heart J Suppl 2005;7:F27-F33.
ABSTRACT
| FULL TEXT
Over-the-Counter Statins
Choudhry and Avorn
ANN INTERN MED 2005;142:910-913.
ABSTRACT
| FULL TEXT
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts
Di Napoli et al.
Cardiovasc Res 2005;66:462-471.
ABSTRACT
| FULL TEXT
The cost of glucocorticoid-associated adverse events in rheumatoid arthritis
Pisu et al.
Rheumatology (Oxford) 2005;44:781-788.
ABSTRACT
| FULL TEXT
Hypertension Management in the Elderly Has Improved: Ontario Prescribing Trends, 1994 to 2002
Tu et al.
Hypertension 2005;45:1113-1118.
ABSTRACT
| FULL TEXT
Statins and the Risk of Colorectal Cancer
Poynter et al.
NEJM 2005;352:2184-2192.
ABSTRACT
| FULL TEXT
Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman et al.
Arch Intern Med 2005;165:1147-1152.
ABSTRACT
| FULL TEXT
Secondary prevention of heart disease with statins: Groups were as different as chalk and cheese
Penston
BMJ 2005;330:1208-1208.
FULL TEXT
Hyperlipidemia in Seniors: Too Much, Too Little, Too Late?
Hirth
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:595-597.
FULL TEXT
The Challenge of Achieving National Cholesterol Goals in Patients With Diabetes
Kennedy et al.
Diabetes Care 2005;28:1029-1034.
ABSTRACT
| FULL TEXT
Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
Sever et al.
Diabetes Care 2005;28:1151-1157.
ABSTRACT
| FULL TEXT
Simvastatin over the counter
DTB 2005;43:25-28.
ABSTRACT
| FULL TEXT
Review: Defining the role of statins in diabetes
Tuomilehto and Leiter
British Journal of Diabetes & Vascular Disease 2005;5:55-62.
ABSTRACT
Modern intervention strategies for managing dyslipidaemia: the case for combination therapy
Drexel
British Journal of Diabetes & Vascular Disease 2005;5:S17-S23.
ABSTRACT
Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Beishuizen et al.
Diabetes Care 2004;27:2887-2892.
ABSTRACT
| FULL TEXT
Implications of recent end-point trials on future management of hypertension and dyslipidaemia
Dahlof
Eur Heart J Suppl 2004;6:G13-G17.
ABSTRACT
| FULL TEXT
Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis
Amarenco et al.
Stroke 2004;35:2902-2909.
ABSTRACT
| FULL TEXT
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial
Nissen et al.
JAMA 2004;292:2217-2225.
ABSTRACT
| FULL TEXT
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis
Brown et al.
CMAJ 2004;171:1189-1192.
ABSTRACT
| FULL TEXT
Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?
Hackam
CMAJ 2004;171:857-857.
FULL TEXT
The case for statins: has it really been made?
Thompson and Temple
JRSM 2004;97:461-464.
FULL TEXT
Therapeutic options for patients with chronic myocardial ischaemia
Serruys and Aoki
Eur Heart J Suppl 2004;6:E2-E11.
ABSTRACT
| FULL TEXT
Update on Statins: 2003
Vaughan and Gotto
Circulation 2004;110:886-892.
FULL TEXT
Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity
Duncan et al.
J. Biol. Chem. 2004;279:33079-33084.
ABSTRACT
| FULL TEXT
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
J Am Coll Cardiol 2004;44:720-732.
ABSTRACT
| FULL TEXT
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:e149-e161.
ABSTRACT
| FULL TEXT
Management of dyslipidaemia
Thompson
Heart 2004;90:949-955.
FULL TEXT
Perspective on Selected Issues in Cardiovascular Disease Research With a Focus on Black Americans
Albert et al.
Circulation 2004;110:e7-e12.
FULL TEXT
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy et al.
Circulation 2004;110:227-239.
ABSTRACT
| FULL TEXT
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
Wilt et al.
Arch Intern Med 2004;164:1427-1436.
ABSTRACT
| FULL TEXT